IFITM2 and pancreatic ductal adenocarcinoma: Recently, it has been reported that pancreatic ductal adenocarcinoma cells are able to release BAG3 which activates macrophages via its binding to the receptor IFITM-2 (interferon-induced transmembrane protein 2) (Rosati et al., 2015).